Profile
John Valliant is the founder of the Centre For Probe Development & Commercialization, holding the title of Independent Director & Principal Investigator since 2008.
Dr. Valliant was the founder of Fusion Pharmaceuticals, Inc., having held the title of Chief Executive Officer & Director from 2014 to 2024.
Dr. Valliant's current job is as a Professor at McMaster University, starting in 1999.
Dr. Valliant's education includes a doctorate from McMaster University.
John Valliant active positions
| Companies | Position | Start |
|---|---|---|
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Founder | 01/03/2008 |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1999 |
Former positions of John Valliant
| Companies | Position | End |
|---|---|---|
| FUSN PHAR | Founder | 04/06/2024 |
Training of John Valliant
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fusion Pharmaceuticals, Inc.
Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
- Stock Market
- Insiders
- John Valliant
















